HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. Tarantino P, Niman SM, Erick TK, Priedigkeit N, et al. Eur J Cancer 2022;174:277-286.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tarantino P, Niman SM, Erick TK, Priedigkeit N, et al. HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. Eur J Cancer 2022;174:277-286.
PMID: 36116830